GINA LUNCAN: Open Payments
NPI 1801316328 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 19 payments from 11 companies in 2025. Trend: 2023 $1,132 · 2024 $662 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $112 |
| Abbott Laboratories | 3 | $77 |
| SCPHARMACEUTICALS INC. | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| CVRx, Inc. | 1 | $20 |
Products named: IN.PACT ADMIRAL, JARDIANCE, FUROSCIX, MITRACLIP, LEQVIO, Kerendia, WAINUA, Assure WCD.
Industry payments across FL — which companies pay providers there.
